We tested our hypothesis in an orthotopic mouse model of pancreatic cancer, using a RAGE-specific monoclonal antibody (IgG 2A11) to inhibit RAGE/ligand interactions. The gene discussed is AGER; the disease is pancreatic neoplasm.